Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1068837 ATLANTA, GA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,896,720
+$608,158 QoQ
Shares Held
425,363
-16.9% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 208 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0% Shared 84% None 16%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. TSHA ranks #58 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 505,219 $250,957,432
2 PTGX
Protagonist Therapeutics, Inc
 571,618 $70,068,932
3 TWST
Twist Bioscience Corp
 671,866 $69,121,573
4 SRRK
Scholar Rock Holding Corp
 890,607 $48,983,385
5 KRYS
Krystal Biotech, Inc.
 124,442 $46,251,357
6 TGTX
Tg Therapeutics, Inc.
 819,253 $45,009,759
7 PTCT
Ptc Therapeutics, Inc.
 539,319 $43,992,249
8 PRAX
Praxis Precision Medicines, Inc.
 122,227 $40,920,376

All Filings in TSHA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,896,720 425,363
2026-03-31 $2,288,562 511,983
2025-12-31 $1,200,017 218,185
2025-09-30 $119,355 36,500
2025-06-30 $108,960 47,169
2025-03-31 $67,576 48,616
2024-12-31 $88,603 51,216
2024-09-30 $110,638 55,044
2024-06-30 $120,812 53,934